LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Atomic Force Microscopy Differentiates Cancerous from Normal Cells

By LabMedica International staff writers
Posted on 29 Apr 2009
Image: Colored scanning electron micrograph (SEM) of the surface of a cervical cancer cell, showing microvilli strands that are small projections of the cell’s cytoplasm (Photo courtesy of Steve Gschmeissner / SPL).
Image: Colored scanning electron micrograph (SEM) of the surface of a cervical cancer cell, showing microvilli strands that are small projections of the cell’s cytoplasm (Photo courtesy of Steve Gschmeissner / SPL).
Using an atomic force microscope, scientists discovered that cancer cells and normal cells had different cell surface properties. The difference in the brush layers covering the cell surface might have a biological significance, and could be used for detection of cancer.

Brushes on the cell surface, mostly consisting of microridges and tiny hairs called microvilli, are important for interacting with the external environment. The investigators processed force measurements--taken from the cell surface using an atomic force microscope--according to a model that accounts for these brushes, to quantitatively show that cancerous cells are different. Normal cells have brushes of one length, whereas cancerous cells have mostly two brush lengths of significantly different densities.

The scientific group was led by Igor Sokolov, director of the Nanoengineering and Biotechnology Laboratories Center at Clarkson University (Potsdam, NY, USA). "Cancer cells are traditionally detected by biochemical means," said Professor Sokolov. "However, despite many years of success, those methods have not resulted in defeating cancer. Therefore, it is very important to search for alternative, nontraditional ways of looking at cancer. Investigation of the physical properties of cell surfaces might be one such nontraditional way."

The authors also demonstrated that the difference found in cell surface "brush" is practically impossible to find with other microscopic methods.

The study appeared online in Nature Nanotechnology, on April 13, 2009.

Related Links:

Clarkson University


Gold Member
Hybrid Pipette
SWITCH
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
ESR Analyzer
TEST1 2.0

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more